# A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

> **NCT05754957** · PHASE3 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 14194 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Milvexian
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05754957
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-07
- **Primary completion:** 2026-02-06
- **Final completion:** 2026-02-06
- **Target enrollment:** 14194 (ACTUAL)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05754957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05754957, "A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05754957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*